| Dr Maria Socorro Ambulo Geronimo, MD | |
|
630 Matthews Township Pkwy, Matthews, NC 28105-5322 | |
| (704) 495-6020 | |
| Not Available |
| Full Name | Dr Maria Socorro Ambulo Geronimo |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 630 Matthews Township Pkwy, Matthews, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811097967 | NPI | - | NPPES |
| 5920787 | Medicaid | NC | |
| 1811097967 | Medicaid | NC | |
| 0114821 | Medicaid | NJ | |
| NC1594 | Medicaid | SC | |
| 25MA07879400 | Other | NJ | STATE LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Willowbrooke Court Sc Ctr At Matthews Glen | Matthews, NC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tryon Medical Partners, Pllc | 7113277971 | 119 |
News Archive
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
New estimates released 9/18/13 from the Office of the Actuary at the Centers for Medicare and Medicaid Services project that aggregate health care spending in the United States will grow at an average annual rate of 5.8 percent for 2012-22, or 1.0 percentage point faster than the expected growth in the gross domestic product.
Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.
Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Melexis, an early and innovative semiconductor player in the RFID market, and ProximaRF, a provider of versatile HF reader solutions, join their forces to enable fast and easy development of Data Logging applications.
› Verified 4 days ago
| Entity Name | Tryon Medical Partners, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992204549 PECOS PAC ID: 7113277971 Enrollment ID: O20180829002057 |
News Archive
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
New estimates released 9/18/13 from the Office of the Actuary at the Centers for Medicare and Medicaid Services project that aggregate health care spending in the United States will grow at an average annual rate of 5.8 percent for 2012-22, or 1.0 percentage point faster than the expected growth in the gross domestic product.
Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.
Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Melexis, an early and innovative semiconductor player in the RFID market, and ProximaRF, a provider of versatile HF reader solutions, join their forces to enable fast and easy development of Data Logging applications.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria Socorro Ambulo Geronimo, MD 5960 Fairview Rd Ste 500, Charlotte, NC 28210-3113 Ph: (704) 495-6334 | Dr Maria Socorro Ambulo Geronimo, MD 630 Matthews Township Pkwy, Matthews, NC 28105-5322 Ph: (704) 495-6020 |
News Archive
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
New estimates released 9/18/13 from the Office of the Actuary at the Centers for Medicare and Medicaid Services project that aggregate health care spending in the United States will grow at an average annual rate of 5.8 percent for 2012-22, or 1.0 percentage point faster than the expected growth in the gross domestic product.
Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.
Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Melexis, an early and innovative semiconductor player in the RFID market, and ProximaRF, a provider of versatile HF reader solutions, join their forces to enable fast and easy development of Data Logging applications.
› Verified 4 days ago
Vidyasagargoud Marupakula, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Healing Way, Matthews, NC 28104 Phone: 980-993-2240 | |
Zelalem Atakilt Gebreananya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-9740 Fax: 704-384-9565 | |
Nusrat Ahmad Chaudhary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 | |
Dr. Henry D Cremisi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5416 Fax: 704-384-5992 | |
Dr. Kevin M. Rudisel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5420 Fax: 704-384-5424 | |
Dr. Abdul Karim Garuba, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9705 Northeast Pkwy Ste 400, Matthews, NC 28105 Phone: 704-844-8971 Fax: 704-844-8972 | |
Dr. Keithe Saclayan Shensky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 Fax: 704-841-9228 |